Ami Organics Limited (AMIORG) - Total Liabilities

Latest as of March 2025: Rs2.29 Billion INR ≈ $24.79 Million USD

Based on the latest financial reports, Ami Organics Limited (AMIORG) has total liabilities worth Rs2.29 Billion INR (≈ $24.79 Million USD) as of March 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Ami Organics Limited - Total Liabilities Trend (2014–2025)

This chart illustrates how Ami Organics Limited's total liabilities have evolved over time, based on quarterly financial data. See Ami Organics Limited (AMIORG) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.

Ami Organics Limited Competitors by Total Liabilities

The table below lists competitors of Ami Organics Limited ranked by their total liabilities.

Company Country Total Liabilities
GeneDx Holdings Corp.
NASDAQ:WGS
USA $252.18 Million
SANOFI CONS HEALTHC IND L
NSE:SANOFICONR
India Rs1.63 Billion
Ramsay Generale De Sante
PA:GDS
France €5.41 Billion
Jiangxi Hungpai New Material Co Ltd
SHG:605366
China CN¥1.15 Billion
Vulcan Energy Resources Limited
AU:VUL
Australia AU$100.10 Million
BLS International Services Limited
NSE:BLS
India Rs9.00 Billion
Guangdong Golden Dragon Development Inc
SHE:000712
China CN¥18.69 Billion
EVEREST MED.LTD DL-0001
F:6HN
Germany €1.53 Billion

Liability Composition Analysis (2014–2025)

This chart breaks down Ami Organics Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Ami Organics Limited market cap and net worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 3.91 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.17 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.15 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Ami Organics Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Ami Organics Limited (2014–2025)

The table below shows the annual total liabilities of Ami Organics Limited from 2014 to 2025.

Year Total Liabilities Change
2025-03-31 Rs2.29 Billion
≈ $24.79 Million
-44.53%
2024-03-31 Rs4.13 Billion
≈ $44.68 Million
+138.84%
2023-03-31 Rs1.73 Billion
≈ $18.71 Million
+26.62%
2022-03-31 Rs1.37 Billion
≈ $14.77 Million
-44.54%
2021-03-31 Rs2.46 Billion
≈ $26.64 Million
+105.15%
2020-03-31 Rs1.20 Billion
≈ $12.99 Million
-8.29%
2019-03-31 Rs1.31 Billion
≈ $14.16 Million
+33.76%
2018-03-31 Rs978.86 Million
≈ $10.59 Million
+39.68%
2017-03-31 Rs700.79 Million
≈ $7.58 Million
+7.87%
2016-03-31 Rs649.65 Million
≈ $7.03 Million
+46.40%
2015-03-31 Rs443.74 Million
≈ $4.80 Million
+58.84%
2014-03-31 Rs279.37 Million
≈ $3.02 Million
--

About Ami Organics Limited

NSE:AMIORG India Specialty Chemicals
Market Cap
$1.18 Billion
Rs108.67 Billion INR
Market Cap Rank
#8360 Global
#399 in India
Share Price
Rs1327.40
Change (1 day)
+8.78%
52-Week Range
Rs1091.40 - Rs1327.40
All Time High
Rs2626.70
About

Acutaas Chemicals Limited engages in the research and development, manufacture, and sale of pharmaceutical intermediates in India and internationally. The company offers pharma intermediates for use in regulated and generic active pharmaceutical ingredients for anti-retroviral, anti-inflammatory, anti-psychotic, anti-cancer, anti-Parkinson's, antidepressant, and anticoagulant applications, as wel… Read more